Search

Search Constraints

You searched for: Author/Creator Schilsky, Michael

Search Results

6. O01 Efficacy and safety of ALXN1840 versus standard of care in Wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial. (20th September 2022)

7. P12 Effect of liver disease, neurological disease and mental health issues on quality of life in patients with wilson disease. (28th September 2020)

8. P13 Major depressive disorder in patients with wilson's disease: relationship with liver disease, neurological disease and quality of life. (28th September 2020)